CIDRAP releases interim update on its Vaccine Integrity Project, spotlighting global threats to vaccine confidence and outlining next steps to support equitable immunization efforts worldwide.

CIDRAP releases interim update on its Vaccine Integrity Project, spotlighting global threats to vaccine confidence and outlining next steps to support equitable immunization efforts worldwide.
We conducted a social listening analysis to assess attitudes towards mRNA vaccines and therapeutics on Twitter from June 2022 to May 2023. Our findings reveal widespread negative sentiment and a global lack of confidence in mRNA vaccines and therapeutics, with frequent discussions of severe vaccine side effects, rumors, and misinformation.
We conducted a social listening analysis to assess attitudes towards mRNA vaccines and therapeutics on Twitter from June 2022 to May 2023.
Join us for the LSHTM Vaccine Centre’s Annual Lecture with Professor Stephan Lewandowsky, exploring practical tools to address vaccine hesitancy. Discover the Empathetic Refutational Interview (ERI) — a proven, human-centred approach for building trust and countering misinformation.
19 May 2025 | 17:30 BST | John Snow Lecture Theatre A
The way to discuss a vaccine, says Prof. Heidi Larson, founding director of the Vaccine Confidence Project, is to ask your patient how they feel about it and go from there, addressing patient concerns and developing a risk-benefit analysis to discuss.
In 2023 around 70% of UK adults said that vaccinations were safe and effective, down sharply from 90% in 2018, according to research from the Vaccine Confidence Project, run by the London School of Hygiene and Tropical Medicine (LSHTM).
As health narratives in the climate change discourse become more visible, the intersection of health and climate change will soon become a critical area vulnerable to misinformation and disinformation campaigns.
The Covid pandemic has provoked a fresh wave of hesitancy. According to VCP data, between 2018 and 2023 confidence in vaccine safety, importance and efficacy fell by about 20% in the UK.
Artificial intelligence has potential to counter vaccine hesitancy while building trust in vaccines, but it must be deployed ethically and responsibly, argue Heidi Larson and Leesa Lin
Heidi J Larson, along with contributors from the Vaccine Confidence Project, discuss the complex factors influencing decision-making around vaccines.
The workshop featured a series of presentations – including from VCP Founder and Co-Director Prof. Heidi J Larson – on the nature, mechanisms, and differential impacts of misinformation about science.
In this interview with the New Book Network, author and Professor Heidi J. Larson discusses the research that informed her book Stuck, and how things have changed since the COVID-19 pandemic.